Clinical Trials Browser

Phase NA × Hodgkin Disease × Rituximab × Clear all

NCT01702961 2018-12-19

Rituxan+BEAM

Phase NA Completed

75 enrolled 8 charts

Hodgkin Disease, Lymphoma

NCT00648037 2016-02-01

Rituximab (Rituxan) for the Prevention of EBV-LPD Epstein Barr Virus (EBV) Lymphoproliferative Disorder Post T Cell Depleted Unrelated and HLA Mis-matched Related HSCT

Phase NA Completed

26 enrolled 6 charts

LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes

NCT00476229 2012-08-07

Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies

Phase NA Completed

20 enrolled 5 charts

LymphoidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell